drugset / Trial / NCT01743677

CP-690,550 Thorough QTc Study

NCT01743677

Phase 1 Completed 60 enrolled Pfizer
RandomizedCrossoverQuadruple-blindOther

Summary

ICH E14 recommends that a thorough QT/QTc (TQT) study should be performed to determine whether intensive monitoring of QT interval in target patient populations is required during later stages of development. The current study is designed to ascertain whether CP-690,550 is associated with QTc prolongation.

Timeline

Start
2007-10-26
Primary completion
2008-02-07
Completion
2008-02-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule 400 mg
Subject Tofacitinib Small molecule 100 mg

Indications

No indication recorded.